Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T22:39:31.198Z Has data issue: false hasContentIssue false

Oleic acid is indispensable for intraerythrocytic proliferation of Plasmodium falciparum

Published online by Cambridge University Press:  05 July 2007

F. MI-ICHI
Affiliation:
Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
S. KANO
Affiliation:
Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan
T. MITAMURA*
Affiliation:
Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
*
*Corresponding author: Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan. Tel: +81-3-3202-7181 ext. 2871. Fax: +81-3-3202-7364. E-mail: tmitamura@ri.imcj.go.jp
Rights & Permissions [Opens in a new window]

Summary

Serum-derived fatty acids are essential for the intraerythrocytic proliferation of Plasmodium falciparum in humans. We previously reported that only limited combinations of fatty acids can support long-term parasite culture, and palmitic acid (C16:0)/oleic acid (C18:1, n-9), palmitic acid (C16:0)/vaccenic acid (C18:1, n-7), or stearic acid (C18:0) are required in these combinations, implying that these fatty acids are key molecules for intraerythrocytic parasite growth (Mi-Ichi et al.2006). Here, we analysed profiles of parasitaemia changes as well as morphologies during the erythrocytic cycle and confirmed the importance of C16:0 and C18:1, n-9. We also provide evidence that C18:1, n-9 but not other C18 monoenoic or dienoic acids maintain the synchronicity of parasite development in serum-free medium when paired with C16:0, resulting in maintained exponential growth. Thus, C18:1, n-9 is indispensable for the intraerythrocytic proliferation of P. falciparum.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007
Figure 0

Fig. 1. Morphologies for normal appearance and abnormal appearance. The morphologies seen in the major populations at each stage are shown. The upper and lower rows indicate normal and abnormal appearances, respectively.

Figure 1

Fig. 2. Growth profiles of parasites in serum-free medium supplemented with reconstituted lipid-associated BSA containing a combination of fatty acids: C16:0 (●); C18:1, n-9 (▲); C16:0/C18:1, n-9 (■). Final concentrations of fatty acids used were C16:0, 30 μm; C18:1, n-9, 30 μm; C16:0/C18:1, n-9, 30 μm/30 μm. The tightly synchronized culture was set at ring with starting parasitaemia at 0·65% (A) and 1·57% (B). Error bar indicates the difference from the average.

Figure 2

Fig. 3. Morphological changes over time of parasites grown in serum-free medium supplemented with reconstituted lipid-associated BSA containing a combination of fatty acids. Parasite morphology was observed under microscopy on Giemsa-stained slides. The fatty acids used are indicated at the left of each row. Final concentrations of fatty acids used were C16:0, 30 μm; C18:1, n-9, 30 μm; C16:0/C18:1, n-9, 30 μm/30 μm. Starting parasitaemia was set at 1·57%.

Figure 3

Fig. 4. Growth profiles of parasites in serum-free medium supplemented with reconstituted lipid-associated BSA containing a combination of fatty acids. (A) C16:0/C18:1, n-9 (●); C16:0/C18:1, n-7 (▲); C16:0/C18:2, n-6 (■). Starting parasitaemia was set at 0·13%. (B) Growth profiles in serum-free medium containing C16:0/C18:2, n-6. Starting parasitaemia: 3·49% (○); 1·57% (Δ); 0·65% (□); 0·13% (■). Final concentrations of fatty acids used were C16:0/C18:1, n-9, 30 μm/30 μm; C16:0/C18:1, n-7, 30 μm/30 μm; C16:0/C18:2, n-6, 30 μm/30 μm. Error bar indicates the difference from the average.

Figure 4

Fig. 5. Distribution of each stage during the course of intraerythrocytic development. Parasitaemia was determined at different stages in cultures grown in serum-free medium supplemented with reconstituted lipid-associated BSA containing a combination of fatty acids. (A) C16:0/C18:1, n-9. (B) C16:0/C18:2, n-6. Parasites of normal appearance and those of abnormal appearance were counted separately. Starting parasitaemia was set at 1·57%. Final concentrations of fatty acids used were C16:0/C18:1, n-9, 30 μm/30 μm; C16:0/C18:2, n-6, 30 μm/30 μm. Error bar indicates the difference from the average.

Figure 5

Fig. 6. Distribution of each stage during the course of intraerythrocytic development. Percentages of total parasites at each stage at 24 h, 36 h, 40 h and 44 h are shown. Only the data for parasites of normal appearance from Fig. 5 were used. Results are expressed as a percentage of the parasitaemia at each stage to total parasitaemia at the indicated time. Error bar indicates the difference from the average.

Figure 6

Fig. 7. Morphological changes over time of parasites grown in serum-free medium supplemented with reconstituted lipid-associated BSA containing a combination of fatty acids. Parasite morphology was observed under microscopy on Giemsa-stained slides. Starting parasitaemia was set at 0·13%. The combinations of fatty acids used are indicated at the left side of each row. Final concentrations of fatty acids used were C16:0/C18:1, n-9, 30 μm/30 μm; C16:0/C18:1, n-7, 30 μm/30 μm; C16:0/C18:2, n-6, 30 μm/30 μm.